Barr Eyes Mid-2008 Launch For Generic Yasmin
Barr Laboratories Inc.'s bid for U.S. food and Drug Administration approval to make and market a generic version of Bayer Schering Pharma AG's oral birth control product Yasmin has been approved,...To view the full article, register now.
Already a subscriber? Click here to view full article